Hida T, Chandler D, Arena J E, Machemer R
Am J Ophthalmol. 1986 Feb 15;101(2):190-5. doi: 10.1016/0002-9394(86)90593-3.
We tested the vehicles of six different commercially available depot corticosteroids (Celestone Soluspan, Depo-Medrol, Decadron, Decadron L. A., Aristocort, and Kenalog) for possible toxicity when injected intravitreally. When tested on rabbit eyes, the Celestone Soluspan and the Depo-Medrol vehicles caused remarkable retinal degeneration with preretinal membrane formation or cataracts in their standard concentrations. Three other vehicles (Decadron and Decadron L. A.) caused localized retinal degeneration in twice the standard concentration. Thus, toxic effects can be caused by preservatives or inadequate osmolarity of the vehicles alone. The development of proliferative vitreoretinopathy in some cases of injections of intraocular depot corticosteroid can be explained by retinal necrosis and repair processes caused by these vehicles.
我们测试了六种不同的市售长效皮质类固醇(康宁克通-A、得宝松、地塞米松、长效地塞米松、曲安奈德和去炎松)的载体在玻璃体内注射时的潜在毒性。在兔眼上进行测试时,康宁克通-A和得宝松的载体在标准浓度下会导致明显的视网膜变性,并伴有视网膜前膜形成或白内障。另外三种载体(地塞米松和长效地塞米松)在两倍标准浓度下会导致局部视网膜变性。因此,单独的防腐剂或载体渗透压不足都可能导致毒性作用。眼内长效皮质类固醇注射的某些病例中增殖性玻璃体视网膜病变的发生可以用这些载体引起的视网膜坏死和修复过程来解释。